These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12484028)

  • 1. [Pharmacologic study of intraperitoneal paclitaxel in gastric cancer patients with peritoneal dissemination].
    Fushida S; Furui N; Kinami S; Ninomiya I; Fujimura T; Nishimura G; Ohta T; Yokogawa K; Miyamoto K; Miwa K
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2164-7. PubMed ID: 12484028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A phase I study of intraperitoneal plus intravenous paclitaxel against gastric cancer with peritoneal dissemination (HGCG 0301)].
    Shinohara H; Okamoto S; Nishitai R; Shirakata Y; Itoi K; Yamagami K; Taki Y; Yamamoto M; Mizuno Y
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2027-31. PubMed ID: 17197747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Safety of intraperitoneal chemotherapy with paclitaxel in gastric cancer patients with peritoneal dissemination].
    Fujitani K; Hirao M; Tsujinaka T
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1855-7. PubMed ID: 15553738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacologic study of intraperitoneal docetaxel in gastric cancer patients with peritoneal dissemination].
    Fushida S; Nao F; Kinami S; Ninomiya I; Fujimura T; Nishimura G; Ohta T; Yokogawa K; Miyamoto K; Miwa K
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1759-63. PubMed ID: 12402426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of intraperitoneal paclitaxel administration in a gastric cancer patient with severely impaired renal function].
    Ohbu M; Maruyama M; Miyawaki Y; Tamura N; Koide A; Hasegawa K; Maruyama S; Takashima I; Ebuchi M
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1745-7. PubMed ID: 16315928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study.
    de Bree E; Rosing H; Filis D; Romanos J; Melisssourgaki M; Daskalakis M; Pilatou M; Sanidas E; Taflampas P; Kalbakis K; Beijnen JH; Tsiftsis DD
    Ann Surg Oncol; 2008 Apr; 15(4):1183-92. PubMed ID: 18239973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal paclitaxel: a possible impact of regional delivery for prevention of peritoneal carcinomatosis in patients with gastric carcinoma.
    Kodera Y; Ito Y; Ito S; Ohashi N; Mochizuki Y; Yamamura Y; Koike M; Fujiwara M; Nakanishi H; Nakao A
    Hepatogastroenterology; 2007; 54(75):960-3. PubMed ID: 17591103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer.
    Ishigami H; Kitayama J; Otani K; Kamei T; Soma D; Miyato H; Yamashita H; Hidemura A; Kaisaki S; Nagawa H
    Oncology; 2009; 76(5):311-4. PubMed ID: 19299904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of gastric cancer with peritoneal dissemination which showed the intraperitoneal CR by administrating TS-1 orally and paclitaxel intraperitoneally].
    Miki H; Tamura S; Wada H; Kozuma Y; Kittaka N; Kim T; Takiuchi D; Aihara T; Sugimoto K; Fukunaga M; Ozato H; Tomita N; Takatsuka Y
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1661-4. PubMed ID: 14619488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of gastric cancer with peritoneal dissemination which shows a remarkable efficacy by a weekly administration of paclitaxel intraperitoneally].
    Kato K; Koide A; Oobu M; Hasegawa K; Maruyama S; Takashima I; Nagahama T; Maruyama M; Ebuchi M
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1852-4. PubMed ID: 15553737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer) in recurrent ovarian cancer: a Gynecologic Oncology Group study.
    Armstrong DK; Fleming GF; Markman M; Bailey HH
    Gynecol Oncol; 2006 Nov; 103(2):391-6. PubMed ID: 16626792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I evaluation of continuous 5-fluorouracil infusion followed by weekly paclitaxel in patients with advanced or recurrent gastric cancer.
    Kondo K; Kobayashi M; Kojima H; Hirabayashi N; Kataoka M; Araki K; Matsui T; Takiyama W; Miyashita Y; Nakazato H; Nakao A; Sakamoto J
    Jpn J Clin Oncol; 2005 Jun; 35(6):332-7. PubMed ID: 15961435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intraperitoneal administration of cisplatin (CDDP) for advanced or recurrent gastric cancer with peritoneal dissemination].
    Miyamoto Y; Morishita Y; Ohwada S; Nakamura S; Takeyoshi I; Tanahashi Y; Kusaba T; Usui R; Minaguchi S; Shiozaki H
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2195-9. PubMed ID: 1444486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer.
    Lee KW; Im SA; Yun T; Song EK; Na Ii; Shin H; Choi IS; Oh DY; Kim JH; Kim DW; Kim TY; Lee JS; Heo DS; Bang YJ; Kim NK
    Jpn J Clin Oncol; 2005 Dec; 35(12):720-6. PubMed ID: 16332718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The current situation and subjects of the intraperitoneal chemotherapy for peritoneal dissemination in gastric cancer].
    Hirono Y; Fujimoto D; Nagano H; Murakami M; Katayama K; Yamaguchi A
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):891-5. PubMed ID: 18633215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-peritoneal administration of paclitaxel with non-animal stabilized hyaluronic acid as a vehicle--a new strategy against peritoneal dissemination of gastric cancer.
    Yamada J; Kitayama J; Tsuno NH; Yamashita H; Miyato H; Soma D; Otani K; Kamei T; Ishigami H; Hidemura A; Kaisaki S; Takahashi K; Nagawa H
    Cancer Lett; 2008 Dec; 272(2):307-15. PubMed ID: 18768251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of recurrent gastric cancer with malignant ascites responding dramatically to chemotherapy with paclitaxel infused systemically and intraperitoneally].
    Morifuji M; Murakami Y; Yokoyama Y; Sasaki M; Hayashidani Y; Toge K; Sueda T
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):2027-30. PubMed ID: 15570933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal administration of Taxol in the management of ovarian cancer.
    Markman M; Rowinsky E; Hakes T; Reichman B; Jones W; Lewis JL; Rubin S; Curtin J; Barakat R; Almadrones L
    J Natl Cancer Inst Monogr; 1993; (15):103-6. PubMed ID: 7912515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Safety and efficacy of chemotherapy using TS-1 followed by paclitaxel for advanced or recurrent gastric cancer with peritoneal dissemination].
    Ohashi M; Kanda T; Yajima K; Banba T; Tanabe T; Kosugi S; Hatakeyama K
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1640-2. PubMed ID: 16315894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of intraperitoneal chemotherapy using new-aged drugs for the peritoneal dissemination of gastric cancer].
    Fushida S; Fujita H; Kinami S; Ninomiya I; Fujimura T; Nishimura G; Ohta T
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1691-4. PubMed ID: 16315911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.